WOCKPHARMANSEWockhardt Limited· PharmaceuticalsLowPositive
Announced Thu, 19 Feb · 15:50 IST

Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Master Circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated 11th November, 2024, we wish to inform you that NSE Sustainability Ratings and Analytics Limited, a SEBI-Registered ESG rating provider, has voluntarily assigned an ESG rating of 65 (Aspiring) for the year 2025 as part of its ESG assessment process.The rating comprises a score of 51 for Environmental, 70 for Social, and 74 for Governance parameters, resulting in the overall ESG score of 65. These underscore the Company s strong ESG commitment with steady progress and solid disclosures.

WOCKPHARMA · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Wockhardt Limited has received an overall ESG rating of 65 ('Aspiring') from NSE Sustainability Ratings and Analytics Limited, a SEBI-registered ESG rating provider, for the year 2025. The rating is broken down into three parameters: Environmental score of 51, Social score of 70, and Governance score of 74. The company described the rating as reflecting its strong ESG commitment with steady progress and solid disclosures. This disclosure was made under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015.

Likely market impact

The ESG rating is moderate-to-positive and reinforces Wockhardt's governance and social practices, though its relatively weaker environmental score (51) may draw investor attention. Overall, the rating is informational and unlikely to cause a sharp stock price move, but it strengthens the company's sustainability profile for ESG-focused investors.